Silencing of Long Noncoding RNA AK139328 Attenuates Ischemia/Reperfusion Injury in Mouse Livers

Zhenzhen Chen, Jia Shi, Danhua Li, Junyan Cai, Jian Tu, Bin Geng, Youfei Guan, Qinghua Cui, Jichun YangPLoS 2013 · DOI

Introduction

Hepatic ischemia/reperfusion (I/R) injury is a major clinical complication in liver transplantation and complex hepatic surgeries. This condition arises when blood flow is temporarily restricted (ischemia) and then restored (reperfusion), triggering oxidative stress, severe inflammation, and cell death. While the roles of proteins and microRNAs in this process are well-documented, the regulatory influence of long noncoding RNAs (lncRNAs)—transcripts longer than 200 nucleotides that do not code for proteins—remains largely unexplored. This study identifies the lncRNA expression profile in mouse livers following I/R and investigates the therapeutic potential of silencing the specific lncRNA AK139328.

Methods

The researchers utilized a mouse model involving 70% partial hepatic ischemia for 60 minutes, followed by 6 hours of reperfusion. LncRNA expression was mapped using the Arraystar Mouse LncRNA Microarray v2.0, with results validated by quantitative PCR (qPCR). To determine the functional role of AK139328, siRNA-mediated knockdown was performed in vivo via tail-vein injection three days prior to the I/R procedure. Liver damage was assessed through plasma enzyme levels (ALT/AST), histological analysis (H&E staining), and Western blotting to monitor survival signaling (Akt pathway) and inflammatory markers (NF-κB pathway).

Results

The LncRNA Landscape of I/R Injury

Microarray profiling identified 98 significantly deregulated lncRNAs in I/R-treated livers, with 71 upregulated and 27 downregulated. AK139328 emerged as a key candidate due to its high expression in normal liver and its sharp increase following injury. Located intergenically on chromosome 2, AK139328 appears to function as a distinct regulatory unit.

AK139328 Silencing Protects Against Liver Damage

Silencing AK139328 via siRNA significantly reduced biochemical markers of liver injury. Plasma ALT and AST activities were reduced by approximately 50% in the knockdown group compared to the control I/R group.

Figure 5: Plasma aminotransferase activity (B) and relative mRNA levels of inflammatory cytokines (C) comparing sham and I/R conditions.

Histological examination corroborated these findings, showing markedly smaller areas of necrosis in mice where AK139328 was silenced.

Figure 4: Histological analysis of liver tissue (200X) showing structural changes following I/R injury.

Modulation of Survival and Inflammatory Signaling

The study found that AK139328 acts as a molecular bridge between survival and death pathways. Silencing the lncRNA activated the protective Akt signaling pathway, increasing levels of phosphorylated Akt (pAkt), GSK3 (pGSK3), and eNOS (peNOS). Simultaneously, knockdown inhibited the pro-inflammatory NF-κB pathway, leading to a significant decrease in inflammatory cytokines (TNF-α, MCP-1, IP-10) and reduced macrophage infiltration.

Discussion

These findings demonstrate that deregulated lncRNAs are central to the pathophysiology of liver I/R injury. AK139328, in particular, exacerbates injury by suppressing survival signals and promoting inflammation. Silencing this lncRNA offers a potent protective effect, suggesting it could be a novel target for diagnosis and treatment in clinical settings such as liver surgery or transplantation. Future research is required to define the exact biochemical interactions of AK139328 and to develop effective clinical delivery systems for lncRNA-targeted therapies.

Summary updated

Abstract

Recently, increasing evidences had suggested that long noncoding RNAs (LncRNAs) are involved in a wide range of physiological and pathophysiological processes. Here we determined the LncRNA expression profile using microarray technology in mouse livers after ischemia/reperfusion treatment. Seventy one LncRNAs were upregulated, and 27 LncRNAs were downregulated in ischemia/reperfusion-treated mouse livers. Eleven of the most significantly deregulated LncRNAs were further validated by quantitative PCR assays. Among the upregulated LncRNAs confirmed by quantitative PCR assays, AK139328 exhibited the highest expression level in normal mouse livers. siRNA-mediated knockdown of hepatic AK139328 decreased plasma aminotransferase activities, and reduced necrosis area in the livers with a decrease in caspase-3 activation after ischemia/reperfusion treatment. In ischemia/reperfusion liver, knockdown of AK139328 increased survival signaling proteins including phosphorylated Akt (pAkt), glycogen synthase kinase 3 (pGSK3) and endothelial nitric oxide synthase (peNOS). Furthermore, knockdown of AK139328 also reduced macrophage infitration and inhibited NF-κB activity and inflammatory cytokines expression. In conclusion, these findings revealed that deregulated LncRNAs are involved in liver ischemia/reperfusion injury. Silencing of AK139328 ameliorated ischemia/reperfusion injury in the liver with the activation of Akt signaling pathway and inhibition of NF-κB activity. LncRNA AK139328 might be a novel target for diagnosis and treatment of liver surgery or transplantation.
BibTeX
@inproceedings{chen2013silencing,
  author = {Zhenzhen Chen and Jia Shi and Danhua Li and Junyan Cai and Jian Tu and Bin Geng and Youfei Guan and Qinghua Cui and Jichun Yang},
  title = {{Silencing of Long Noncoding RNA AK139328 Attenuates Ischemia/Reperfusion Injury in Mouse Livers}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0080817},
}
Figure